Caveolin-1-mediated sphingolipid oncometabolism underlies a metabolic vulnerability of prostate cancerJody V. Vykoukal, Timothy C. Thompson, Adriana Paulucci-Holthauzen et al.|Nature Communications|2020Cited by 83